Monday, December 23, 2024
Facebook Linkedin Twitter
HomeTagsImmunitas Therapeutics

Immunitas Therapeutics

Biotechnology

Immunitas Therapeutics Appoints Annalisa D’Andrea, Ph.D., as Chief Scientific Officer

News Desk -
Immunitas Therapeutics, a clinical stage precision immunotherapy company committed to discovering and developing novel, differentiated therapeutics for patients with cancer, announced the appointment of...
Biotechnology

Immunitas Therapeutics Announces Appointment of James Wooldridge as Chief Medical Officer and Upcoming Presentation at ASH 2023 Annual Meeting

News Desk -
Immunitas Therapeutics, a clinical stage precision immunotherapy company committed to discovering and developing novel, differentiated therapeutics for patients with cancer, announced the appointment of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us